The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Can Nasal Tissue Be Used to Repair a Damaged Knee Joint?

Can Nasal Tissue Be Used to Repair a Damaged Knee Joint?

October 28, 2016 • By Lisa Rapaport

  • Tweet
  • Email
Print-Friendly Version / Save PDF

(Reuters Health)—Doctors might one day be able to harvest cells from patients’ noses to produce cartilage that can be transplanted into damaged knee joints, a small experiment suggests.

You Might Also Like
  • Newly Discovered Molecule Modulates Cartilage Repair
  • Telomere Length Provides Insights into Cartilage Aging and Repair
  • Knee Surgery for Pain May Not Be Worthwhile

Because the experiment only included 10 adults who were followed for just two years, it’s impossible to say for sure whether this procedure would be safe or effective with widespread use. But the results are promising enough to merit more testing, says study co-author Ivan Martin of the University of Basel in Switzerland.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“We have developed a new promising approach to the treatment of articular cartilage injuries,” Martin says by email. “Before this can be offered to patients as a standard treatment, obviously it needs to be tested in larger patient cohorts and in randomized and controlled trials with long-term assessment of clinical outcome.”

Previous research has found cells extracted from the septum can be used to grow new cartilage in a lab, Martin says. With the current experiment, researchers successfully implanted this lab-grown tissue into knee joints for the first time, he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

To do this, researchers first performed a minimally invasive procedure using local anesthesia to harvest a small specimen, about 6 mm or a quarter of an inch, of tissue from the nasal septum.

Next, they grew the harvested cells in a lab for two weeks, then cultured them for another two weeks on a collagen membrane scaffold to grow thin sheets of cartilage measuring 30 mm by 40 mm, or about 1.2 inches by 1.5 inches.

Researchers trimmed these grafts to the right shape to replace the damaged cartilage removed from each patient’s knee joint, then implanted the replacement tissue.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Two years after reconstructive surgery, most recipients reported improvements in pain, knee function and quality of life, researchers reported Oct. 22 in The Lancet.

MRI scans at two years also showed the growth of new tissue similar to native knee cartilage around where the replacement tissue was implanted, the study found.

Researchers didn’t see any adverse reactions or dangerous side effects.

Every year, around 2 million people in the U.S. and Europe alone are diagnosed with damage to articular cartilage because of injuries or accidents, the researchers note.

Because the tissue doesn’t have its own blood supply, it has limited capacity to repair itself once damaged, leading to degenerative joint conditions, such as osteoarthritis.

Traditional methods to prevent or delay onset of cartilage degeneration don’t create the healthy cartilage needed to endure the forces of everyday movement, the authors contend.

Pages: 1 2 | Single Page

Filed Under: Conditions, Osteoarthritis Tagged With: cartilage, knee, knee injury, Knee Osteoarthritis (OA), nasal tissue, nose, surgery

You Might Also Like:
  • Newly Discovered Molecule Modulates Cartilage Repair
  • Telomere Length Provides Insights into Cartilage Aging and Repair
  • Knee Surgery for Pain May Not Be Worthwhile
  • New Methodology to Improve Cartilage Repair

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)